申请人:Grove Simon James Anthony
公开号:US20080139529A1
公开(公告)日:2008-06-12
The present invention relates to benzoxazepine derivative having the general formula I, wherein X represents CO or S0
2
; R
1
, R
2
, R
3
and R
4
are independently selected from H, (C
1-4
)alkyl, (C
1-4
)alkyloxy, (C
1-4
)alkyloxy(C
1-4
)alkyl, halogen, nitro, cyano, NR
8
R
9
, NR
8
COR
10
, and CONR
8
R
9
, R
5
, R
6
and R
7
are independently H or (C
1-4
)alkyl; R
8
and R
9
are independently H or (C
1-4
)alkyl; or R
8
and R
9
form together with the nitrogen atom to which they are bound a 5- or 6-membered saturated heterocyclic ring, optionally containing a further heteroatom selected from O, S or NR
11
; R
10
is (C
1-4
)alkyl; R
11
is (C
1-4
)alkyl; A represents the residue of a 4-7 membered saturated heterocyclic ring, optionally containing an oxygen atom, the ring being optionally substituted with 1-3 substituents selected from (C
1-4
)alkyl, (C
1-4
)alkyloxy, hydroxy, halogen and oxo; or a pharmaceutically acceptable salt thereof. The invention also relates to pharmaceutical compositions comprising said derivatives, and to the use of these benzoxazepine derivatives in the treatment of neurological diseases and psychiatric disorders which are responsive to enhancement of synaptic responses mediated by AMPA receptors in the central nervous system.
本发明涉及一种具有一般式I的苯并噁唑啉衍生物,其中X代表CO或S02; R1、R2、R3和R4独立地选择自H、(C1-4)烷基、(C1-4)烷氧基、(C1-4)烷氧基(C1-4)烷基、卤素、硝基、氰基、NR8R9、NR8COR10和CONR8R9,R5、R6和R7独立地为H或(C1-4)烷基; R8和R9独立地为H或(C1-4)烷基; 或R8和R9与它们所结合的氮原子一起形成一个5-或6-成员饱和杂环环,可选含有进一步选择自O、S或NR11的杂原子; R10为(C1-4)烷基; R11为(C1-4)烷基; A代表4-7成员饱和杂环环的残基,可选含有氧原子,该环可选地用1-3个取代基选择自(C1-4)烷基、(C1-4)烷氧基、羟基、卤素和氧代基取代; 或其药学上可接受的盐。本发明还涉及包含所述衍生物的制药组合物,以及利用这些苯并噁唑啉衍生物治疗中枢神经系统中介导AMPA受体的突触反应增强的神经疾病和精神障碍的用途。